SIM
OGN icon

Studio Investment Management’s Organon & Co OGN Stock Holding History

Studio Investment Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,131
Closed -$201K – 107
2021
Q3 		$201K Buy
+6,131
New +$196K 0.09% 104

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Studio Investment Management's OGN Position: Q4 2021 in Review

Studio Investment Management sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 6,131 shares — an estimated $201K sold.

Studio Investment Management first reported a position in OGN in Q3 2021 and held it in 1 quarter. The position peaked at $201K in Q3 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

  • Studio Investment Management reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
  • Studio Investment Management sold 6,131 Organon & Co shares in Q4 2021, an estimated $201K.
  • Studio Investment Management first reported a position in Organon & Co in Q3 2021 and held it in 1 quarter.
  • Studio Investment Management's Organon & Co position peaked at $201K in Q3 2021.
  • 907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Studio Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.